The hiological and molecular mechanisms which are responsible for the formation and possible evolution of human aneurysms are unknown. Previous investigations have pointed to the possible involvement of inositol specific-phospholipase C (PLC) in the mechanisms related to the formation or evolution of intracranial aneurysms, but, thus far, a relationship of one or more PLC isoforms with the biological signals influencing the fate of this lesion has not been demonstrated. The aim of this study was to investigate the expression, activity and possible modification of PLC isoforms in intracranial aneurysms in patients undergoing elective surgical repair after casual identification of unruptured aneurysms, or during emergency surgical repair of ruptured aneurysms. PLC and proliferating cell nuclear antigen (PCNA) expressions were detected by immunoistochemical analysis; PLC activity was obtained by measuring its hydrolytic activity on labelled PIP z; PKC activity was measured by total kinase activity assay. Results indicated no substantial differences between controls and aneurysms, with the only exception being PLC 82 which was nearly absent in controls and ruptured aneurysms, while strongly expressed and functionally active in almost all un ruptured aneurysms. In addition, its expression always correlated with the proliferation cell marker PCNA, while its specific activity always correlated to PKC activity. PLC 82 distribution, regulation and role in human tissues are still unknown Therefore, although preliminary, these data provide a novel insight into the signalling machinery influencing the aneurismal progression. PLC is a family of enzymes playing a crucial role in transmembrane signalling of various cells, subdivided into four groups: beta (131, 132, 133, 134), gamma (')'1, ')'2), delta (81,82,83,84) and the
Despite the high incidence of intracranial aneurysms, investigations aimed at the identification of its pathogenesis and factors promoting their rupture, have provided, so far, little that is elusive. Many of the suggested pathogenic mechanisms derived from studies performed on animals rather than humans and this is due to the need of handling this intracranial event with the utmost delicacy (1) (2) (3) (4) (5) . As the majority of the results reported in the literature are derived from autopsies, they are influenced by post-mortem reactions, even in samples obtained soon after autopsy. In addition, a number of studies performed on humans and rats, indicate that inositol-specific phospholipase C (PLC) is one of the environmental factors playing a role in the evolution of intracranial aneurysms as well as in peripheral aneurysms (6) (7) (8) . Nevertheless, the involvement of this enzyme in the machinery responsible for the fate of intracranial or peripheral aneurysms, has not been, to date, demonstrated. novel epsilon (9) . These enzymes are capable of catalyzing the hydrolysis of a membrane glycolipid, phosphatidylinositol bis-phosphate (PIP), thereby generating two distinct second messengers, inositol tris-phosphate (IP}) and diacylglycerol (DAG). IP} is responsible for an increase of intracellular calcium concentration, whereas DAG is a potent activator of a serine-threonine kinase, the protein kinase C (PKC) whose role in the control of cell proliferation or differentiation has been widely documented (10) (11) . The occurrence of PLC involvement in the molecular events regulating the cell cycle has been highlighted in many cellular systems (12) (13) (14) and a role of these enzymes in the mechanisms leading to cell protection activated by cell damage, has also been reported (15) . Therefore, in order to shed more light on the molecular events characterizing the evolution of human aneurysms, the present study was undertaken to investigate the expression, activity and possible modification ofPLC isoforms in patients undergoing elective surgical repair of unruptured intracranial aneurysms, or during surgical emergency of intracranial aneurismal rupture.
MATERIALS AND METHODS

Tissue and cell culture
Tissue samples and related controls were obtained from 7 informed, consenting patients affected by unruptured intracranial aneurysmand from 16 patients undergoing emergency surgery following the rupture of an intracranial aneurysm and whose closest relatives consented to biopsies. All patients were from regions of Central Italy. Biopsies were performed by clipping, removing the aneurismal collar and immediately fixing or freezing them. Control tissues from every patient were obtained from a biopsy of the middle meningeal artery. Patients with hypertension, diseases of connective tissue, atherosclerosis or diabetes were excluded from the study. Bovine Aortic Endothelial Cells (BAEC) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, L-glutamine (2mM), penicillin G (100 units/mI), and streptomycin (100mg/ml) at 37°C in 5% humid COz atmosphere.
Cell extracts and PLC immunocomplexes
Tissue homogenates were resuspended in 10mM Tris-HCl buffer pH 7.4, 1% Nonidet P-40 (NP-40), 150 mM NaCl, l mg/ml Bovine Serum Albumin, 1mM
Vanadate, 50 mM Sodium Fluoride. For anti-PLC immunoprecipitation, celllysates (20 mg of proteins) were incubated for 60 minutes at 4°C with anti-PLC [31, [32, [33, [34, )'1, )'2, 81, 82 and 84 antibodies previously coupled to magnetic beads coated with secondary antibodies. Immunocomplexes were collected by a magnet and washed several times with RIPA buffer (10 mM Tris-HCl buffer pH 7.4, 1% NP-40, 0.5% sodium deoxycholate, 0.1 % sodium dodecyl sulphate) in the presence of proteases inhibitors.
PIPz-specijic PLC activity assay
PIPz-specific PLC activity was investigated using a [3H]-labelled PIP 2 exogenous substrate containing equal amounts of dried cold PIP2 and [3H] -PIP z(specific activity 30000 dpm/nmol, Amersham). Briefly, 20 mg of proteins from homogenated human intracranial aneurismal biopsies or, when required, equal amounts of immunocomplexes were incubated in 3 nmol [3H]_ PIP z (as exogenous substrate), 150 mM NaCl, 10 mM 2-(N-morpholino)ethane-sulfonic acid (MES), 0.06 % taurodeoxycholate, 10 mM CaCl z at 37°C for 30 min. Inositol lipid extraction was performed in chloroformmethanol-chloric acid (1:2:0.1).After two washes in methanol/1 M chloric acid (1: 1), the lipid phase was chromatographed on silica gel plates in chloroformmethanol-ammonium hydroxide-water (45: 35:2:8) and spots, identified using PIP z standards, were scraped off and counted by liquid scintillation.
Immunohistochemical analysis
Immunohistochemical analysis was performed essentially as previously described (16) . Briefly, serial sections were deparaffinated and hydrated into distilled Hp through a series of graded alcohols (ethanol 100 %,95 %,70 %). Endogenous peroxidases were inhibited by washing for 15 min in 3 % HP2' The slides were then incubated with rabbit policlonal IgG anti-PLC: 19) , (Santa Cruz Biotechnology, Santa Cruz, CA), 84 (experimental polyclonal IgG, kindly provided by Dr. S. G. Rhee) and anti-proliferating cell nuclear antigen (PCNA;Santa Cruz Biotechnology, Santa Cruz, CA), at the dilution of I :50 in Tris Buffered Saline (TBS) (50 mM Tris-HCl, pH 7,6::±:O,2; 0,9 % NaCl) for 90 min. at room temperature. PLC 83 was not investigated since the appropriate antibody is not available commercially yet. TBS was used in negative controls instead of the primary antibodies. The immunoperoxidase assay was carried out with an immunostaining kit Ultraystain Polyvalent Strept ABC-HRP (Yelm, Rome Italy) and the antibody localization was detected by AEC kit (YLEM, Rome, Italy), according to the manufacturer's suggestions. The sections were washed with H 2 0 , counterstained with Mayer's hemallume (Sigma, St. Louis, MS. USA) for several minutes and then rinsed copiously in tap water. Glicerinated gelatin (Sigma, St. Louis, MS. USA) was used for coverslipping the sections. The histological diagnosis was blindly performed by three different observers. Morphology of correspondent sections was demonstrated by Hematoxylin/Eosin staining (Sigma, St. Louis, MS. USA) the Manufacturer's procedure.
Total PKC activity assay 40 mg of proteins from homogenated human intracranial aneurismal biopsies were incubated in a reaction mixture containing 10 mg histone III-SS, 10 mg phosphatidylserine 50 mM diacylglycerol, 0.5 mM EGT A, 2.5 mM MgC1 2.50 mM sodium orthovanadate, 1 mM PMSF, 50 mM adenosine trisphosphate (ATP), 1 mCi [_ 32P] ATP (3,000 Ci/mmol) and 10 mM Tris-HCl (pH 7.5 at 4°C). Proteins were separated by SDS-PAGE and gels were dried and exposed to X-ray films. Peptides spots were excised and radioactivity was measured by means of liquid scintillation.
Total DNA synthesis in BAEC DNA synthesis was measured by incubating the cells with 20 mM 3[H]_TTP (250 cprn/pmol.). At the indicated times, aliquots were spotted on glass fibre filters (Whatman GF/C) and measured by means of liquid scintillation.
Data analysis
Differences between mean values of groups were tested for statistical significance either with Student's t or, where applicable with one-way analysis-of-variance (ANOVA).
RESULTS
The immunohistochemical analysis aimed at the identification of PLC isoforms expression throughout the layers of the intracranial aneurysmal walls. We noted that all the PLC isoforms were expressed similarly in all the aneurismal samples, and they were undetectable to barely present, with the exception of PLC 82 which was very faint or absent in the controls and in ruptured aneurysms, while it was strongly expressed throughout the arterial wall in 6 of the 7 cases of unruptured intracranial aneurysms (found casually during diagnosis) ( Fig. I A-C ; Table I ). Based on these observation we sought to determine the activity of PLC 82 by means of an in vitro PIP z hydrolytic assay. This evidenced that in the unruptured aneurysms, the total hydrolytic activity was higher in both controls and ruptured samples, and that such activity largely belonged to PLC 82 isoform (Tables II and III) . Since PLC involvement in the mechanisms of cytoprotection activated by cell damage has been highlighted (14) , and a role of these enzymes has also been proposed in the molecular events regulating cell proliferation and repair (11) (12) (13) , we addressed our attention to the identification of a possible relationship between the expression of PLC 82 and the expression of a proliferating cell marker, the proliferating cell nuclear antigen (PCNA), in both ruptured and unruptured aneurismal samples. Results highlighted that, when expressed, PLC 82 directly correlated with the expression ofPCNA ( Fig. I D-F) . In order to shed further light on PLC 82-related signalling, we also investigated any possible PLC 82-dependent PKC activity in both ruptured and unruptured aneurysms by means of a total PKC activity assay. This analysis evidenced that PKC activity was higher in unruptured than in ruptured aneurysms (Table IV) , indicating a strict signalling interaction between PLC 82 isoform and PKC. To investigate whether such signalling might be involved in endothelial cell proliferation, we cultured Bovine Aortic Endothelial Cells (BAEC) in the presence or absence of the PKC inhibitor Rottlerin, and measured at indicated times the level of DNA synthesis by means of the analysis of 3 [H]_TTP incorporation into the cells. Results indicated that, with respect to control, the inhibition of PKC activity was paralleled by a progressive decrease of total DNA synthesis (Table V) . 
DISCUSSION
Investigation on human intracranial aneurysms has, so far, provided little information about the biological and molecular events which drive, or at least characterize this pathology (17) (18) . Developments in technologies, such as Serial Analysis of Gene Expression (SAGE) have recently been used in the attempt to provide genetic approaches to the comprehension of the molecular pathology of these affections by measuring specific gene transcriptional levels (18) . Nevertheless such random analyses, failed to demonstrate correlation between the level of different gene transcription and biological events occurring to cells or tissues. In addition, these studies are usually based on a single case. Therefore the need to extend the study to a wider set consisting of examples both ruptured and unruptured aneurysms using immunoistochemical techniques seemed appropriate (18) . Among the signalling proteins claimed to have a possible role in the evolution of aneurysms, PLC has been proposed in both animal and human models. In fact, analyses of a PLC gene and PLC activity have been reported in studies related to rat intrasaccular aneurysms (7) and in patients with subarachnoid hemorrhage due to ruptured intracranial saccular aneurysm (6) . Although these data suggest some involvement ofPLC machinery in the evolution of intracranial aneurysms, little information is available about selective expression and activity of given PLC isoforms in the structures of normal and saccular (aneurysm) in intracranial arteries. In this article we report for the first time, to our knowledge, specific immunohistochemical and biochemical results from a set of patients with undiagnosed intracranial aneurysm or in subjects undergoing emergency surgery following the rupture of the aneurysm. These results indicate that a unique expression of PLC 82 characterized the differential evolution of intracranial aneurysms. In fact, PLC 82 was strongly expressed in unruptured aneurismal samples, while in the walls of all ruptured aneurysms that we studied, there was little or no expression of this isoform. These results, along with the demonstration of a concomitant selective activation of the hydrolytic activity of this isoform, strongly fit with novel findings indicating that that this enzyme might be closely involved in the mechanisms related to the cell cycle control (16) . Indeed, since PLC 82 was largely expressed in most of the patients with unruptured intracranial aneurysms, it might be supposed that the expression and activity of this enzyme is required to activate a proliferation/ repair activity addressed to the structures undergoing the aneurismal morphological alteration. In this context, the direct correlation of the PLC 82 expression with the amount of PCNA expression, and the strict relationship between PLC 82 and PKC activities found in our studies, strengthen the hypothesis that this isoform is involved in the signalling machinery regulating the cell cycle events, influencing, in turn, the proliferation/repair levels. This possibility fits well with previous data indicating that inhibition of PKC activity results in a decrease of the rate of cell proliferation promoting, on the other hand, cell differentiation (19) (20) . The details of its role in such a regulation remain to be clarified since the human sequence of PLC 82, its mode of activation and action are still ' unknown. PLC 82 was isolated from the bovine brain library (21) and its localization in human tissues has not been completely analyzed (16) . For these reasons the specific antibody so far commercially available and used for our experiments is based on the bovine sequence (human reactive, as indicated by the manufacturer). Because of the lack of information about the genetic picture and the precise biological meaning of this PLC isoform, our laboratory has focused attention on sequencing the human PLC 82, in the attempt to shed more light on the involvement of this protein in the mechanisms regulating the evolution of human aneurysms. Certainly, PLC 82 is not the sole candidate responsible for such a regulation, since a number of other proteins such as COL or P proteins have been included in studies aimed at understanding the machinery controlling tissue rearrangements (18, (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . Nevertheless, our data could be a valuable resource for designing future studies ofthe pathogenesis and evolution of human intracranial aneurysm. Indeed, PLC 82 may become, after further characterization, one of the potential targets for non-invasive screening and therapeutic strategies in the management of such a pathology. 
